Reaction profile

The FDA adverse-event record for insomnia

Name: Insomnia - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

11 FDA reports name insomnia, a lower-volume reaction in the CVM extract (VeDDRA 1557). Plate stamps and neighbourhood peers follow.

#2425 of 2,481
by report volume (all reactions): 11
reports citing this reaction: 0.0%
death-coded share: Human
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Insomnia has 11 reports now versus 11 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Insomnia changes

FDA AER · VeDDRA plate

Code 1557 VOL-TRACE

VOL-TRACE · DEATH-RARE · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-HUMAN · DRUG-LEAD · DESK-NARROW · BOOK-FULL

VOL-TRACE 11 reports
DEATH-RARE 0.0%
BOTTOM-DECILE #2425/2481
PHOTO-FINISH ABNORMAL PANCREATIC S…
SPECIES-HUMAN Human · 11
DRUG-LEAD Enrofloxacin · 4
DESK-NARROW 1 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: ABNORMAL PANCREATIC SPECIFIC LIPASE (PLI) (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Insomnia

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Insomnia

Insomnia: low death-coded share in the FDA AER plate

Signature read: 11 reports place Insomnia in the lower third of FDA AER volume (#2425 of 2,481). Report volume is lower-third scale: 11 named reports in the openFDA extract. Death-coded share is lower-third: 0 of 11 reports (0.0% of named reports). Nearest volume peer: ABNORMAL PANCREATIC SPECIFIC LIPASE (PLI) (±0 reports). Lead species Human (11). Lead co-reported drug Enrofloxacin (4).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Enrofloxacin appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Human 11

Breeds Most Affected

Unknown 11

Associated Drugs

Enrofloxacin 4

Oclacitinib Maleate 2

Cyclosporine 2

Ivermectin 0.5% Pour-On 1

Metformin 1

Imidacloprid + Moxidectin 1

Unspecified Soap 1

Electrolyte Replacement Sports Drink 1

Gonadorelin Injectable 1

Cloprostenol 263 Inj Cattle 1

Alpha-Tocophérol + Ciclosporine + Ethanol + Excipient + Propylèneglycol 1

Bupropion 1

Sertraline 1

Olmesartan 1

Pantoprazole 1

Vitamin D3 1

Acetaminophen 1

Naproxen 1

Aluminum Hydroxide 1

Magnesium Hydroxide 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Insomnia (#2425 of 2,481 by report volume); death-coded 0.0%. PlainBreed reaction plate · report volume stamp 11 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →